July 22nd, 2023

On Tuesday, July 25, several prominent companies are scheduled to release their financial results, including: Microsoft Corporation (Nasdaq: MSFT), a global technology leader, will reveal its fiscal-year 2023 fourth-quarter results after the marke. Read more

July 22nd, 2023

Gilead Sciences, Inc. (Nasdaq: GILD) announced the termination of the Phase 3 ENHANCE study evaluating magrolimab plus azacitidine as a first-line treatment for higher-risk myelodysplastic syndromes (HR-MDS) due to futility based on a planned analysi. Read more

July 22nd, 2023

The Boeing Company (NYSE: BA) was awarded a substantial contract modification worth $393,091,720 for Apache AH-64E aircraft, alongside support services and equipment.  The Army Contracting Command at Redstone Arsenal, Alabama, is responsible . Read more

July 22nd, 2023

According to a regulatory filing with the SEC, Booz Allen Hamilton Holding Corporation (NYSE: BAH) has reached a significant settlement agreement with the U.S. Department of Justice (DOJ) and on behalf of the Defense Contract Management Agency to res. Read more

July 21st, 2023

Mirati Therapeutics, Inc. (Nasdaq: MRTX) faced a setback when the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the Conditional Marketing Authorisation Application (MAA) for its dr. Read more

July 21st, 2023

Shares of Digital World Acquisition Corp. (Nasdaq: DWAC) surged more than 15% after settling fraud charges with the SEC. The charges were related to material misrepresentations made in forms filed during DWAC's initial public offering and its planned. Read more

July 21st, 2023

Evertec, Inc. (NYSE: EVTC) and Sinqia have entered a definitive agreement for Evertec's acquisition of Sinqia, a prominent player in Brazil's financial services software market. The deal is set at a value of R$27.19 per share, with a potential daily . Read more

July 20th, 2023

According to a regulatory filing with the SEC, Evelo Biosciences, Inc. (Nasdaq: EVLO) has entered into a Sublease Termination and Surrender Agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO). The agreement terminates the Sublease, which provided E. Read more

July 20th, 2023

FOR IMMEDIATE RELEASE 2023-135 Washington D.C. / CRWE PRESS RELEASE / July 20, 2023 -  The Securities and Exchange Commission today announced settled fraud charges against Digital World Acquisition Corporation (DWAC), a special purpose . Read more

July 20th, 2023

Pasithea Therapeutics Corp. (Nasdaq: KTTA) has authorized a $4.0 million share repurchase plan (through a tender offer), to buy approximately 5.7 million shares of its outstanding common stock at $0.70 per share. The company's executive officers a. Read more